from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3135/PPE50

LFCtreatmentdescriptionclass of inhibitor

1.188

Amikacinug/mL Amikacintranslation

1.328

Cap5-10ug/mL Capreomycintranslation

2.047

Rox10-50 ug/mL Roxithromycintranslation

-0.073

SM2-5 ug/mL Streptomycintranslation

2.747

Tet5-10 ug/mL Tetracyclinetranslation

-0.004

Rif0.2-5ug/mL Rifampicintranscription

0.056

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.338

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.258

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.049

CPZ10-50 ug/mL Chlorpromazinerespiration

0.303

Clofazimine10-13 ug/mL Clofaziminerespiration

0.676

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.306

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.887

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.349

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.612

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.672

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.330

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.010

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.674

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.128

KCN5-20 ug/mL Potassium cyaniderespiration

0.301

NaN30.2-2 mM Sodium aziderespiration

-0.092

Nigericin50 uM Nigericinrespiration

-0.105

TRC10-150 ug/mL Triclosanrespiration

0.386

TRZ10-25 ug/mL Thioridazinerespiration

-0.301

Valinomycin0.5-10 uM Valinomycinrespiration

2.352

ZnSO42 mM ZnSO4respiration

-0.120

menadione6-10 ug/mL Menadionerespiration

-0.328

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.259

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.304

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.085

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.149

NRP_1Non-replicating persistence stage 1dosRassociated

-0.042

Amp0.2mg/mL AmpicillincellWall

0.312

Cephalexin20-100 ug/mL CephalexincellWall

1.377

Cerulenin0.32-5 ug/mL CerulenincellWall

0.149

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.563

EMB10-20 ug/mL EthambutolcellWall

0.202

Eta12-40 ug/mL EthionamidecellWall

1.092

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.154

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.070

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.110

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.438

BZA0.12 mg/mL BenzamidearomaticAmides

-1.009

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.664

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.066

H2O24 mM hydrogen peroxideDNAdamaging

0.360

Levo10 ug/mL LevofloxacinDNAdamaging

0.032

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.124

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.824

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.353

UVUV-irradiationDNAdamaging

-0.287

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.030

Antimycin12.5-50 ug/mL Antimycin A?

-0.120

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.473

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.572

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.051

PA8240.2-2 ug/mL PA-824?

0.484

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.509

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.238

Verapamil50 uM Verapamil?

0.195

mercaptoethanol2 mM 2-Mercaptoethanol?

0.196

methoxatin10-20 ug/mL Methoxatin?